 
                    Crispr Stem & Therapeutics (CST) Israeli Company
Crispr Stem & Therapeutics (CST) is developing a patented cardio-protective CRISPR-based stem cell protocol to restrict the damage to the heart following acute heart attack and chronic heart failure.
                                                                    
                                        Health Tech & Life Sciences
                                    
                                                            
                                            Alternatives
No alternatives listed yet.
Suggest an Alternative
Office Locations
                                        
                                        Petah Tikva, Israel
                                    
                                                            References
                    
                    
                        [1]
                    
                    
                    
                                    
                        
                            finder.startupnationcentral.org
                        
                        - https://finder.startupnationcentral.org/company_page/crispr-stem-therapeutics-cst
                        
                        
                    
                External links are provided for reference and verification purposes.
